Performance and cost of a renal cancer specialist multidisciplinary team meeting: Results from 1500 discussions
- 14 February 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Clinical Urology
- Vol. 12 (4) , 314-319
Abstract
To report on the performance and cost of a surgeon-led renal cancer specialist multidisciplinary team meeting at a high-volume centre. Retrospective analysis of 1500 consecutive cases discussed from 2 September 2015 onwards. Performance was assessed as the number of cases where a clinical recommendation was made. The cost per meeting, discussion and patient were calculated using the mid-point of pay band attributable to the attendees (National Health Service pay scales 2015). Over 34 meetings, 1500 discussions occurred (933 patients: 61.7% male; mean age 63.8). Above a one-quarter of discussions (n = 399, 26.6%) were new referrals. Each patient’s case was discussed a mean of 1.6 times, the majority being discussed once (n = 563, 60.3%). In 93.3% of discussions, a clinical recommendation was made. Only 100 discussions (6.7%) were deferred due to incomplete clinical information. A total of 11.1% (n = 166) cases were discharged. The average costs were: £141,901 per year, £2729 per meeting, £62 per case discussed and £99 per patient. One discussion was usually sufficient to decide management; deferral was uncommon; and, given the low discharge rate, referrals seemed appropriate. The cost per patient was modest, and represented good value in providing a focused and shared clinical decision-making pathway for renal cancer patients. 2CKeywords
This publication has 12 references indexed in Scilit:
- Multidisciplinary Team Meetings in Cancer Care: An Idea Whose Time has Gone?Clinical Oncology, 2015
- SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus processBMJ Quality & Safety, 2015
- Reviewing Cancer Care Team EffectivenessJournal of Oncology Practice, 2015
- Improving Decision Making in Multidisciplinary Tumor Boards: Prospective Longitudinal Evaluation of a Multicomponent Intervention for 1,421 PatientsJournal of the American College of Surgeons, 2013
- Variation in reported experience of involvement in cancer treatment decision making: evidence from the National Cancer Patient Experience SurveyBritish Journal of Cancer, 2013
- Are multidisciplinary teams in secondary care cost-effective? A systematic review of the literatureCost Effectiveness and Resource Allocation, 2013
- Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 womenBMJ, 2012
- A multidisciplinary approach to the management of urologic malignancies: Does it influence diagnostic and treatment decisions?Urologic Oncology: Seminars and Original Investigations, 2011
- The Central Urology Multidisciplinary Team – Is it Time to Change the Referral Criteria? An Audit of Practice in a District General Hospital in LondonThe Annals of The Royal College of Surgeons of England, 2009
- Multidisciplinary teams in cancer care: are they effective in the UK?The Lancet Oncology, 2006